Publications
116
Citations
4,864
Est. group size
~13
Recurring co-author estimate
Active years
39
Publishing since 1987
Garrie J. Haas's research focuses on heart failure and dilated cardiomyopathy, including genetic causes, family screening, and treatment outcomes for patients with weakened or enlarged hearts. Much of this work is part of the DCM Precision Medicine Study, a large collaborative effort examining how genetics, family history, and lifestyle factors contribute to dilated cardiomyopathy, alongside studies on heart transplant care and mechanical/device-based heart failure therapies.
Publication output has grown over the past decade, rising from about 1-3 papers per year before 2020 to roughly 5-7 per year in 2022-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Implementing Precision Medicine for Dilated Cardiomyopathy: Insights From the DCM Consortium
Circulation Genomic and Precision Medicine · 2025
- Alcohol Exposure Among Patients With Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine Study
Circulation Genomic and Precision Medicine · 2025
- Routine Voriconazole Prophylaxis in Heart Transplant Recipients and Incidence of Non-Melanoma Skin Cancer
The Journal of Heart and Lung Transplantation · 2025
- Antecedent Flu-Like Illness and Onset of Idiopathic Dilated Cardiomyopathy: The DCM Precision Medicine Study
Circulation Heart Failure · 2025
- Evaluation of Women with Peripartum or Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine Study
medRxiv · 2025
- Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial
Circulation · 2024
- Effect of Beta Blockers on Exercise Capacity, Diastolic Function, and Quality of Life in Patients with Heart Failure with Preserved Ejection Fraction: A Secondary Analysis of INDIE-HFpEF and RELAX
medRxiv · 2024
- Implementing Precision Medicine for Dilated Cardiomyopathy: Insights from The DCM Consortium
medRxiv · 2024
- Antecedent flu-like illness and onset of idiopathic dilated cardiomyopathy: The DCM Precision Medicine Study
medRxiv · 2024
- Abstract 4145506: Cardiac Myosin Inhibitors Improve Hemodynamics and Symptom Burden in Symptomatic Hypertrophic Cardiomyopathy: An Updated Meta-Analysis
Circulation · 2024
- A retrospective analysis of anticoagulant safety among heart transplant recipients undergoing endomyocardial biopsy
Clinical Transplantation · 2024
- Outcomes of Heart Transplant Recipients with Highly Elevated Donor-Derived Cell-Free DNA Values: A Single Center Experience
The Journal of Heart and Lung Transplantation · 2024
- Rare Variant Genetics and Dilated Cardiomyopathy Severity: The DCM Precision Medicine Study
Circulation · 2023
- Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives
Journal of the American College of Cardiology · 2023
- Effectiveness of the <i>Family Heart Talk</i> Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial
Circulation · 2023
- Circulation×5
- The Journal of Heart and Lung Transplantation×5
- medRxiv×4
- Circulation Genomic and Precision Medicine×3
- JAMA×2
- Khadijah Breathett
Medicine · Indiana University
- William T. Abraham
Medicine · The Ohio State University
- Peter S. Pang
Medicine · Indiana University
- Hanyu Ni
Medicine · The Ohio State University
- Onyedika J. Ilonze
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile